We observe that orlistat not only binds to fatty acid synthase (FASN) (ΔE = -13.7 Kcal/mol; experimentally known target) but also binds to several other molecules in the obesity network. This evidence concerns the gene FASN and obesity due to melanocortin 4 receptor deficiency.